Studies on PRRSV vaccination: interleukin-12 to enhance the immune response to killed vaccinte and combination vaccine with MLV and killed vaccines
June 2, 2003
PRRSV vaccine efficacy remains controversial. The currently available PRRSV vaccines, either modified live (MLV) or killed virus (KV) vaccines, often appear to provide insufficient protective...
